{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?registeredInterest=false&hansardHeading=Visual+Impairment%3A+Medical+Treatments&max-answer.dateOfAnswer=2017-07-12", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?registeredInterest=false&hansardHeading=Visual+Impairment%3A+Medical+Treatments&max-answer.dateOfAnswer=2017-07-12", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?registeredInterest=false&_metadata=all&hansardHeading=Visual+Impairment%3A+Medical+Treatments&max-answer.dateOfAnswer=2017-07-12", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0®isteredInterest=false&hansardHeading=Visual+Impairment%3A+Medical+Treatments&max-answer.dateOfAnswer=2017-07-12", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?registeredInterest=false&hansardHeading=Visual+Impairment%3A+Medical+Treatments&max-answer.dateOfAnswer=2017-07-12", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?registeredInterest=false&hansardHeading=Visual+Impairment%3A+Medical+Treatments&max-answer.dateOfAnswer=2017-07-12", "items" : [{"_about" : "http://data.parliament.uk/resources/748193", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/748193/answer", "answerText" : {"_value" : "

It is for local National Health Service commissioners to make decisions on whether to fund new treatments, taking into account National Institute for Health and Care Excellence guidance, available evidence and individual patient\u2019s clinical circumstances.<\/p>

<\/p>

The future availability of any new or novel treatments would be subject to large scale clinical trials demonstrating the safety and efficacy of the treatment approach and subsequent assessments of its cost effectiveness for routine use.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2017-07-07", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-07-07T09:56:28.037Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-07-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Visual Impairment: Medical Treatments"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, when magnetic implants to improve eyesight will be available on the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "2707"} , {"_about" : "http://data.parliament.uk/resources/448323", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/448323/answer", "answerText" : {"_value" : "

It is for local National Health Service commissioners to make decisions on whether to fund new treatments, taking into account the National Institute for Health and Care Excellence (NICE) guidance, available evidence and individual patient\u2019s clinical circumstances.<\/p>

<\/p>

NICE issued interventional procedures guidance on the insertion of a subretinal prosthesis system for retinitis pigmentosa in December 2015. NICE\u2019s recommendation was that this procedure should only be used in the context of research, due to the limited evidence being available on its safety and efficacy.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1201", "label" : {"_value" : "Biography information for Alistair Burt"} } , "answeringMemberConstituency" : {"_value" : "North East Bedfordshire"} , "answeringMemberPrinted" : {"_value" : "Alistair Burt"} , "dateOfAnswer" : {"_value" : "2016-02-04", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-02-04T16:56:32.64Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2016-01-27", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Visual Impairment: Medical Treatments"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, when he expects that retinal implant chips will be available through the NHS to treat blindness.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "24432"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }